iShares Biotechnology ETF $IBB Shares Sold by Harbour Investment Management LLC

Harbour Investment Management LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 11.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 25,620 shares of the financial services provider’s stock after selling 3,167 shares during the quarter. iShares Biotechnology ETF accounts for approximately 2.3% of Harbour Investment Management LLC’s portfolio, making the stock its 10th largest holding. Harbour Investment Management LLC owned 0.05% of iShares Biotechnology ETF worth $4,326,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Dynamic Wealth Strategies LLC grew its holdings in shares of iShares Biotechnology ETF by 16.6% in the 4th quarter. Dynamic Wealth Strategies LLC now owns 422 shares of the financial services provider’s stock worth $71,000 after acquiring an additional 60 shares during the period. Flagship Private Wealth LLC boosted its position in iShares Biotechnology ETF by 2.0% during the fourth quarter. Flagship Private Wealth LLC now owns 3,084 shares of the financial services provider’s stock worth $521,000 after purchasing an additional 60 shares in the last quarter. Larson Financial Group LLC boosted its position in iShares Biotechnology ETF by 2.3% during the fourth quarter. Larson Financial Group LLC now owns 2,717 shares of the financial services provider’s stock worth $458,000 after purchasing an additional 60 shares in the last quarter. Webster Bank N. A. grew its holdings in iShares Biotechnology ETF by 1.0% in the fourth quarter. Webster Bank N. A. now owns 6,476 shares of the financial services provider’s stock valued at $1,093,000 after purchasing an additional 62 shares during the last quarter. Finally, Choreo LLC boosted its position in shares of iShares Biotechnology ETF by 2.2% in the 4th quarter. Choreo LLC now owns 3,043 shares of the financial services provider’s stock worth $514,000 after buying an additional 65 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $190.19 on Wednesday. The firm has a 50-day moving average price of $172.03 and a two-hundred day moving average price of $171.35. iShares Biotechnology ETF has a twelve month low of $125.70 and a twelve month high of $191.15.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Monday, June 15th were issued a $0.0238 dividend. This represents a $0.10 annualized dividend and a dividend yield of 0.1%. The ex-dividend date of this dividend was Monday, June 15th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.